Replimune Group, Inc. — Director's Dealing 2023

Apr 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2023-04-01

Reporting Person: Oliger Christy J. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-01	Stock Option (right to buy)	$17.66	A	25200	Acquired	2033-04-01	Common Stock (25200)	Direct

Footnotes

F1: The shares underlying this option vest entirely on April 1, 2024.